S100A9 and hepatocellular carcinoma: Additionally, S100A9 has been identified as a diagnostic biomarker for various cancers, including HCC, with its elevated expression correlating with HBV-positive HCC tissues and promoting growth and metastasis in vitro and in vivo [277,280].